BIOTECH & PHARMA

    Biotech and pharma stocks listed on the ASX.

    Optiscan ASX OIL cancer Memorial Sloan Kettering Centre clinical trial

    Optiscan secures major milestone after approval for prestigious cancer trial

    Oventus Medical ASX OVN O2Vent Optima sleep apnoea treatment clinics

    Oventus Medical to roll-out sleep apnoea treatment across US sleep clinics

    Impression Healthcare commences obstructive sleep apnoea clinical trial

    Impression Healthcare ASX IHL Incannex Pharmaceuticals medicinal cannabis oil supply cannabinoid

    Impression Healthcare secures long term oil supply agreement, unveils new cannabis discovery brand Incannex

    Telix Pharmaceuticals ASX TLX phase two prostate cancer imaging study GenesisCare

    Telix Pharmaceuticals to begin phase two prostate cancer imaging study

    Elixinol ASX EXL Altmed Pets Pet Releaf

    Elixinol Global strikes exclusive multimillion-dollar deal with Pet Releaf

    Paradigm Biopharmaceuticals ASX PAR US investigational new drug

    Paradigm submits first investigational new drug application with US FDA

    Opthea ASX OPT positive clinical trial macular degeneration

    Opthea achieves positive vision trial, eyes further clinical trials

    Phylogica ASX PYC human cell penetrating peptide blinding eye disease

    Phylogica’s cell peptide delivery platform achieves early success in human cell studies for blinding eye diseases

    Cannvalate IPO Dr Amit Vohra medicinal cannabis Sonic Healthcare ASX SHL

    Cannvalate strengthens board by recruiting Sonic Healthcare senior executive ahead of IPO

    ImExHS FDA exemption Hiruko Essential ASX IME

    ImExHS receives FDA exemption and plots course to commercialise US market

    ONE Championship Impression Healthcare ASX IHL mouthguard concussion research CBD

    Impression Healthcare becomes official supplier and research partner to ONE Championship

    Cann Group ASX CAN manufacturing licence cannabis Melbourne

    Cann Group picks up manufacturing licences for existing facilities

    Bod Australia ASX BDA medicinal cannabis prescriptions MediCabilis

    Bod Australia reveals ‘significant’ growth in medicinal cannabis prescriptions, more to come

    Orthocell ASX OCC CelGro nerve repair pre-clinical study

    Orthocell’s latest pre-clinical study underlines CelGro performance in nerve repair

    Dr Sud Agarwal Impression Healthcare ASX IHL Cannvalate cannabis

    Impression Healthcare appoints leading medicinal cannabis pioneer Dr Sud Agarwal to its board

    MGC Pharmaceuticals ASX MXC cannabinoids brain cancer research cannabis

    MGC Pharmaceuticals presents ‘ground-breaking’ research into effect of cannabis on brain cancer

    Phylogica ASX PYC study results Cell Penetrating Peptide CPP platform

    Phylogica obtains successful time-course study results for flagship CPP platform

    Patrys ASX PAB glioblastoma brain tumour cancer animal model PAT-DX1

    Animal data shows potential for Patrys’ PAT-DX1 drug to help radiation fight aggressive brain tumours

    Kazia Therapeutics ASX KZA Memorial Sloan Kettering Cancer Center radiotherapy clinical trial

    Kazia Therapeutics unveils fresh clinical trial for its brain cancer drug candidate

    Bod Australia ASX BDA NewH2 Health & Happiness cannabis hemp CBD

    Bod Australia receives major capital boost via Health & Happiness Group’s innovation arm

    Load more
    Small Caps ASX Australian stock market
    Small Caps is Australia's #1 site for market news & information on ASX listed small cap companies.

    Small Caps and affiliated companies accept no responsibility for any claim, loss or damage as a result of information provided or its accuracy. The information provided on this site is general in nature, not financial product advice, see a financial expert before making any investment decision. Your personal objectives, financial situation or needs have not been taken into consideration. There may be a conflict of interest present with commercial arrangements with companies and/or stock held. Small Caps or an associate may receive a commission for funds raised.
    Copyright 2019 Small Caps. All rights reserved.